Navigation Links
Medicsight PLC Presents New Data at RSNA 2008 Further Supporting Relevance of Computer-Aided Detection (CAD) and Image Analysis Software in Early Colon Cancer Screening and Diagnosis
Date:12/3/2008

roach - [December 3, 3:40 PM CST]. The study compares performances of different experienced readers using a primary 3D flythrough approach with and without the use of CAR analysis, and shows that when less experienced readers are assisted by CAR it can increase their sensitivity.

  • Abstract #LL-GI5109: Computer-aided Detection in CT Colonography: Help or Hindrance? A Fly-through Approach to the Latest Concepts [Educational Exhibit on display throughout duration of RSNA]. The presentation summarizes how the clinical implementation of CAD in CTC is evolving as an accurate, safe and acceptable method of colonic investigation in both symptomatic patients and for colorectal cancer screening.

The Medicsight ColonCAD software automatically highlights suspicious areas on computerized tomography scans of the colon, helping radiologists to identify, measure and analyze potential disease and early indicators of disease. Medicsight's CAD software has been validated using one of the world's largest and most population diverse databases of verified patient CT scan data.

CT colonography offers a safe, rapid and minimally invasive means of imaging the entire colon. Medicsight's ColonCAD software works by automatically highlighting suspicious lesions on CTC scans, thereby detecting possible malignant tumors at an earlier stage when treatment is more likely to be successful.

Medicsight has already gained regulatory approval for marketing its ColonCAD software product in Europe, Canada, Australia, China and Brazil. Medicsight anticipates ColonCAD will become available for clinical use in Japan by end of 2008 and the U.S., pending clearance by the FDA, during the first half of 2009. The CAD software will be made available through Medicsight's partners: Vital Images Inc, Viatronix Inc, TeraRecon Inc, Barco N.V., 3me
'/>"/>

SOURCE Medicsight PLC
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine news :

1. MGT Capital Investments, Inc. is Delighted with the Announcement of Medicsights Commercial Agreement with Toshiba PACS Division
2. Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser
3. Medicsight ColonCAD Technology Successfully Identified Cancer in 100% of Patients Included in Data Presented at ESGAR 2008
4. Medicsight Announces New Global Marketing Partnership with Ziosoft Unveiled at RSNA 2008
5. Updated GOLD report presents new understandings in diagnosis, treatment and prevention of COPD
6. The Art Of Maternity(TM) at Destination Maternity(R) Presents A Sacred Passage Into Motherhood; the Art of Belly Masking to Belly Casting
7. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
8. VNUS Medical Technologies Presents at William Blair Small-Cap Growth Stock Conference
9. NARSAD - Worlds Leading Mental Health Research Charity - Presents 19th Annual New York Mental Health Symposium, Oct. 19th & 20th
10. Retirement Living TV Presents Sex, Drugs and Rock N Roll
11. AviaraDx Presents at 2007 BIOCOM Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine Technology:Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 2Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 3Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 4Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 2Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 3Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 4Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 5Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 6Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 7Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 8